Ziemssen, T., & Gilgun-Sherki, Y. (2015). Sub-analysis of geographical variations in the 2-year observational COPTIMIZE trial of patients with relapsing–remitting multiple sclerosis converting to glatiramer acetate. BMC Neurol.
استشهاد بنمط شيكاغوZiemssen, Tjalf, و Yossi Gilgun-Sherki. "Sub-analysis of Geographical Variations in the 2-year Observational COPTIMIZE Trial of Patients With Relapsing–remitting Multiple Sclerosis Converting to Glatiramer Acetate." BMC Neurol 2015.
MLA استشهادZiemssen, Tjalf, و Yossi Gilgun-Sherki. "Sub-analysis of Geographical Variations in the 2-year Observational COPTIMIZE Trial of Patients With Relapsing–remitting Multiple Sclerosis Converting to Glatiramer Acetate." BMC Neurol 2015.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.